134 related articles for article (PubMed ID: 28245368)
1. [Clinical and Immunophenotypic Properties of Small Cell Variant of T-cell Prolymphocytic Leukemia].
Yu YP; Wang LP; Song P; Mei JG; An ZM; Zhou XG; Li F; Tang YM; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):8-15. PubMed ID: 28245368
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Nair R; Sengar M; Nair C
Indian J Cancer; 2010; 47(2):189-93. PubMed ID: 20448385
[TBL] [Abstract][Full Text] [Related]
3. T-Cell Prolymphocytic Leukemia, Small Cell Variant, Possibly at the Stage of Intracytoplasmic Expression of CD3 in T-Cell Ontogenesis.
Yoshioka Y; Nagao M; Saitoh T; Yoshioka S; Tsunemine H; Itoh K; Kodaka T; Takahashi T
J Clin Exp Hematop; 2015; 55(1):17-21. PubMed ID: 26106002
[TBL] [Abstract][Full Text] [Related]
4. Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis.
Jeong KH; Lew BL; Sim WY
Acta Derm Venereol; 2009; 89(5):509-12. PubMed ID: 19734979
[TBL] [Abstract][Full Text] [Related]
5. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
Sugimoto T; Imoto S; Matsuo Y; Kojima K; Yasukawa M; Murayama T; Kohfuku J; Mizuno I; Yakushijin K; Sada A; Nishimura R; Koizumi T
Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117
[TBL] [Abstract][Full Text] [Related]
7. Small cell variant of T-cell prolymphocytic leukemia with a gammadelta immunophenotype.
Toyota S; Nakamura N; Dan K
Int J Hematol; 2005 Jan; 81(1):66-8. PubMed ID: 15717692
[TBL] [Abstract][Full Text] [Related]
8. A case of T cell prolymphocytic leukemia involving blast transformation.
Ichikawa K; Noguchi M; Imai H; Sekiguchi Y; Wakabayashi M; Sawada T; Komatsu N
Int J Hematol; 2011 May; 93(5):667-672. PubMed ID: 21505955
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia.
Miyata A; Kojima K; Yoshino T; Fujii S; Shinagawa K; Ichimura K
Int J Hematol; 2001 Feb; 73(2):230-5. PubMed ID: 11372737
[TBL] [Abstract][Full Text] [Related]
10. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases.
Hoyer JD; Ross CW; Li CY; Witzig TE; Gascoyne RD; Dewald GW; Hanson CA
Blood; 1995 Aug; 86(3):1163-9. PubMed ID: 7620169
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of T-cell prolymphocytic leukemia (T-PLL) with fludarabine monophosphate].
Maeda A; Iwai K; Ishibashi T
Rinsho Ketsueki; 2009 Aug; 50(8):658-62. PubMed ID: 19915381
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
13. T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
Hu Z; Medeiros LJ; Xu M; Yuan J; Peker D; Shao L; Tang Z; Mai B; Thakral B; Rios A; Hu S; Wang W
Am J Clin Pathol; 2023 Apr; 159(4):325-336. PubMed ID: 36883805
[TBL] [Abstract][Full Text] [Related]
14. T-cell prolymphocytic leukemia (T-PLL) with overlapping cytomorphological features with T-CLL and T-ALL: a case initially diagnosed by fine-needle aspiration cytology and immunocytochemistry.
Das DK; Pathan SK; Joneja M; Al-Musawi FA; John B; Mirza KR
Diagn Cytopathol; 2013 Apr; 41(4):360-5. PubMed ID: 21987484
[TBL] [Abstract][Full Text] [Related]
15. CD30-positive EBV-associated diffuse large B-cell lymphoma occurring after immunosuppressive therapy for T-cell prolymphocytic leukemia.
Alduaij A; Treaba DO; Winer ES
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):64-7. PubMed ID: 21454193
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features of aggressive natural killer cell leukemia].
Liu EB; Chen HS; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):810-4. PubMed ID: 22336205
[TBL] [Abstract][Full Text] [Related]
17. CD20-positive T-cell chronic lymphocytic leukaemia.
Takami A; Saito M; Nakao S; Asakura H; Nozue T; Onoe Y; Yachie A; Shiobara S; Matsuda T
Br J Haematol; 1998 Sep; 102(5):1327-9. PubMed ID: 9753064
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
Chen X; Cherian S
Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphatic leukemias of T and NK cell type.
Kingreen D; Siegert W
Leukemia; 1997 Apr; 11 Suppl 2():S46-9. PubMed ID: 9178839
[TBL] [Abstract][Full Text] [Related]
20. T-cell prolymphocytic leukemia in a 63-year-old female with a pre-existing T-cell large granular lymphocytic leukemia: metachronous T-cell leukemias with discordant subset restrictions (CD4 versus CD8) and distinct clonal identities.
Wei Q; Papavassiliou P; Rehder C; Sebastian S; Wang E
Pathol Res Pract; 2014 Dec; 210(12):1100-5. PubMed ID: 25238936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
